arrow
Back
N

Neal J. Meropol

harvard university medical affiliates

73H-index
436Paper Count
2.9WCitation Count
Published Papers 105
Publication Date
Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201
err2026-01-01
err0
errOAAI
errKam, Audrey E.; Zhao, Fengmin; Meropol, Neal J.; Giantonio, Bruce J.; Diasio, Robert B.; Flynn, Patrick J.; Catalano, Paul; Hartner, Lee; Rowland, Kendrith M.; Song, Wei; Mulcahy, Mary F.; Sinicrope, Frank A.; Whitehead, Robert P.; Mayer, Robert J.; Petrelli, Nicholas; O'dwyer, Peter J.; Hamilton, Stanley R.; Cella, David; Benson, Al B.
errShare
errSave
Optimizing public-private partnerships to support clinical cancer research
err2024-12-12
err0
PREAI
errHerbst, Roy S.; Blumenthal, Gideon; Khleif, Samir N.; Lippman, Scott M.; Meropol, Neal J.; Rosati, Kristen; Shulman, Lawrence N.; Smith, Heind; Wang, Meina; Winn, Robert A.; Schilsky, Richard L.
errShare
errSave
Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies
err2024-09-26
err0
PREAI
errPrindiville, Sheila A.; Mandrekar, Sumithra J.; Meropol, Neal J.; Denicoff, Andrea; Grad, Oren; Hautala, Judith A.; Doroshow, James H.
errShare
errSave
Are community oncology practices with or without clinical research programs different? A comparison of patient and practice characteristics
err2024-07-23
err2
errOAAI
errAltomare, Ivy; Wang, Xiaoliang; Kaur, Maneet; Guadamuz, Jenny S.; Falk, Sam; Xiao, Forrest; Meropol, Neal J.; Zhao, Yihua
errShare
errSave
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)
err2024-07-05
err0
errOAAI
errMezzanotte-Sharpe, Jessica; ONeill, Anne; Mayer, Ingrid A.; Arteaga, Carlos L.; Yang, Ximing J.; Wagner, Lynne I.; Cella, David; Meropol, Neal J.; Alpaugh, R. Katherine; Saphner, Thomas J.; Swaney, Robert E.; Hoelzer, Karen L.; Gradishar, William J.; Abramson, Vandana G.; Sundaram, P. Kothai; Jilani, Shamim Z.; Perez, Edith A.; Lin, Nancy U.; Jahanzeb, Mohammad; Wolff, Antonio C.; Sledge, George W.; Reid, Sonya A.
errShare
errSave
Digital Health Applications in Oncology: An Opportunity to Seize
err2022-05-31
err21
errOAAI
errParikh, Ravi B.; Basen-Enquist, Karen M.; Bradley, Cathy; Estrin, Deborah; Levy, Mia; Lichtenfeld, J. Leonard; Malin, Bradley; McGraw, Deven; Meropol, Neal J.; Oyer, Randall A.; Sheldon, Lisa Kennedy; Shulman, Lawrence N.
errShare
errSave
The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials
err2022-04-01
err6
errOAAI
errVanderWalde, Noam; Moughan, Jennifer; Lichtman, Stuart M.; Jagsi, Reshma; Ballo, Matthew; VanderWalde, Ari; Mohiuddin, Mohammed; Meropol, Neal J.; Kachnic, Lisa; Berger, Adam; Ajani, Jaffer; Anne, Rani; Hopkins, Judith L.; Arora, Amit; Meyer, Joshua; Ellsworth, Susannah G.; Lee, R. Jeffrey; Green, Nathan; Crane, Christopher H.
errShare
errSave
Adherence to and determinants of guideline- recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice
errCANCER
IF5.1
err2021-03-17
err2
errOAAI
errLau-Min, Kelsey S.; Li, Yimei; Eads, Jennifer R.; Wang, Xiaoliang; Meropol, Neal J.; Mamtani, Ronac; Getz, Kelly D.
errShare
errSave
5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers
err2020-11-03
err67
errOAAI
errZhao, Yiqing; Feng, Xiujing; Chen, Yicheng; Selfridge, J. Eva; Gorityala, Shashank; Du, Zhanwen; Wang, Janet M.; Hao, Yujun; Cioffi, Gino; Conlon, Ronald A.; Barnholtz-Sloan, Jill S.; Saltzman, Joel; Krishnamurthi, Smitha S.; Vinayak, Shaveta; Veigl, Martina; Xu, Yan; Bajor, David L.; Markowitz, Sanford D.; Meropol, Neal J.; Eads, Jennifer R.; Wang, Zhenghe
errShare
errSave
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
err2020-06-17
err10
errOAAI
errEads, Jennifer R.; Krishnamurthi, Smitha S.; Saltzman, Joel; Bokar, Joseph A.; Savvides, Panos; Meropol, Neal J.; Gibbons, Joseph; Koon, Henry; Sharma, Neelesh; Rogers, Lisa; Pink, John J.; Xu, Yan; Beumer, Jan H.; Riendeau, John; Fu, Pingfu; Gerson, Stanton L.; Dowlati, Afshin
errShare
errSave
Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action
err2020-04-05
err25
errOAAI
errTakvorian, Samuel U.; Balogh, Erin; Nass, Sharyl; Valentin, Virginia L.; Hoffman-Hogg, Lori; Oyer, Randall A.; Carlson, Robert W.; Meropol, Neal J.; Sheldon, Lisa Kennedy; Shulman, Lawrence N.
errShare
errSave
Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts
err2020-03-01
err19
errOAAI
errD'Amico, Thomas A.; Bandini, Lindsey A. M.; Balch, Alan; Benson, Al B., III; Edge, Stephen B.; Fitzgerald, C. Lyn; Green, Robert J.; Koh, Wui-Jin; Kolodziej, Michael; Kumar, Shaji; Meropol, Neal J.; Mohler, James L.; Pfister, David; Walters, Ronald S.; Carlson, Robert W.
errShare
errSave
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis
err2019-12-16
err12
PREAI
errParikh, Ravi B.; Feld, Emily K.; Galsky, Matthew D.; Adamson, Blythe J. S.; Cohen, Aaron B.; Baxi, Shrujal S.; Ben Boursi, Shimon; Christodouleas, John P.; Vaughn, David J.; Meropol, Neal J.; Mamtani, Ronac
errShare
errSave
Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer
err2019-10-01
err37
errOAAI
errFeld, Emily; Harton, Joanna; Meropol, Neal J.; Adamson, Blythe J. S.; Cohen, Aaron; Parikh, Ravi B.; Galsky, Matthew D.; Narayan, Vivek; Christodouleas, John; Vaughn, David J.; Hubbard, Rebecca A.; Mamtani, Ronac
errShare
errSave
Validation of diagnosis codes to identify side of colon in an electronic health record registry
err2019-08-19
err21
errOAAI
errLuhn, Patricia; Kuk, Deborah; Carrigan, Gillis; Nussbaum, Nathan; Sorg, Rachael; Rohrer, Rebecca; Tucker, Melisa G.; Arnieri, Brandon; Taylor, Michael D.; Meropol, Neal J.
errShare
errSave
Development and initial validation of a prognostic score based on structured data from EHRs
err2019-07-01
err1
PREAI
errBackenroth, Daniel; Haimson, Josh D.; Meropol, Neal J.; Baxi, Shrujal S.
errShare
errSave
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer
err2019-05-01
err14
errOAAI
errBagley, Stephen J.; Talento, Suzanna; Mitra, Nandita; Meropol, Neal J.; Cohen, Roger B.; Langer, Corey J.; Vachani, Anil
errShare
errSave
COST-EFFECTIVENESS OF MULTI-GENE PANEL SEQUENCING FOR PATIENTS WITH ADVANCED MELANOMA
err2019-05-01
err0
errOAAI
errSteuten, L.; Goulart, B.; Meropol, N.; Pritchard, D.; Ramsey, S. D.
errShare
errSave
Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)
err2019-03-14
err6
errOAAI
errEl-Deiry, Wafik S.; Winer, Arthur; Slifker, Michael; Taylor, Stanford; Adamson, Blythe J. S.; Meropol, Neal J.; Ross, Eric A.
errShare
errSave
Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists
err2019-03-01
err12
PREAI
errKim, Simon P.; Shah, Nilay D.; Meropol, Neal J.; Tilburt, Jon C.; Nguyen, Paul L.; Yu, James B.; Abouassaly, Robert; Kim, Albert; Gross, Cary P.
errShare
errSave